Page last updated: 2024-12-09

n-fluorobenzenesulfonimide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-fluorobenzenesulfonimide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID588007
CHEMBL ID1338788
SCHEMBL ID121410
MeSH IDM0514751

Synonyms (72)

Synonym
AC-1252
n-fluorobenzenesulfonimide, 97%
MLS001359884 ,
smr001224404
n-fluorobenzenesulfonimide
n-fluoro-n-(phenylsulfonyl)benzenesulfonamide
AN-584/43417535
n-(benzenesulfonyl)-n-fluorobenzenesulfonamide
inchi=1/c12h10fno4s2/c13-14(19(15,16)11-7-3-1-4-8-11)20(17,18)12-9-5-2-6-10-12/h1-10h
n-fluoro-n-phenylsulfonylbenzenesulfonamide
rlkhfsnwqczbdc-uhfffaoysa-
133745-75-2
n-fluorobis(phenylsulfonyl)amine
F0335
nfsi
nfbs
A26032
n-fluorobis(phenylsulfonyl)amine;n-fluorodibenzenesulfonamide;n-fluorodibenzenesulfonimide
AKOS005254552
n-(benzenesulfonyl)-s-phenylfluoranesulfonamido
n-fluorobenzensulfonimide
HMS3059D10
bis(phenylsulfonyl)fluoroamine
n-fluorodibenzenesulfonimide
n-fluorodi(benzenesulfonyl)amine
n-fluorodi(benzenesulfonyl)amine; n-fluorodibenzenesulfonimide; nfsi
c12h10fno4s2
accufluor nfsi
n-fluorobenzenesulphonimide ,
n-fluorodibenzenesulfonamide
FT-0643204
n-fluorobis(phenylsulphonyl)amine
benzenesulfonamide, n-fluoro-n-(phenylsulfonyl)-
n-fluorodi(benzenesulfonyl)-amine
n-benzenesulfonyl-n-fluorobenzenesulfonamide
n-(benzenesulfonyl)-n-fluoro-benzenesulfonamide
n-fluoro benzene sulfonimide
(phso2)2nf
n-fluorodibenzene sulfonamide
n-fluoro-n-(phenylsulfonyl)benzene-sulfonamide
n-fluorobenzene-sulfonimide
n-fluoro-bis(phenylsulfonyl)amine
n-fluoro-di(benzenesulfonyl)-amine
n-fluoro benzenesulfonimide
n-fluorobenzene sulfonimide
n-fluoro-bis (phenylsulfonyl) amine
SCHEMBL121410
AM81140
FD2002
SY001955
mfcd00144885
CHEMBL1338788
n-fluoro-n-(phenylsulfonyl)benzenesulfonamide #
Q-201466
(18f)-n-fluorobenzenesulfonimide
unii-38tgl3a00i
n-fluorobenzenesulfonimide [mi]
38TGL3A00I ,
n-besyl-n-fluoro-benzenesulfonamide
cid_588007
n-fluoranyl-n-(phenylsulfonyl)benzenesulfonamide
bdbm80338
F0001-0448
CS-D1051
GS-3616
DTXSID10343177
BCP00988
EN300-56237
n-fluorobenzenesulfonmide
Q27256818
SB40754
n-fluoro dibenzenesulfonic amide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.07520.003245.467312,589.2998AID2517
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency39.81070.631035.7641100.0000AID504339
thioredoxin glutathione reductaseSchistosoma mansoniPotency44.66840.100022.9075100.0000AID485364
chromobox protein homolog 1Homo sapiens (human)Potency100.00000.006026.168889.1251AID540317
serine/threonine-protein kinase PLK1Homo sapiens (human)Potency26.67950.168316.404067.0158AID720504
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency15.84890.050127.073689.1251AID588590
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA dC->dU-editing enzyme APOBEC-3G isoform 1Homo sapiens (human)IC50 (µMol)55.30000.270026.3638100.0000AID504719
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (9.68)29.6817
2010's24 (77.42)24.3611
2020's4 (12.90)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.81 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index45.47 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (96.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]